Generics Industry Sounds Alarm Over Northern Ireland Requirements As Deadline Looms

‘UK Only’ Labeling And Biological Testing Threaten Supply Ahead Of 1 January 2025

 
• By Dave Wallace
  
The BGMA says Windsor Framework requirements put supply at risk (Shutterstock)

More from Biosimilars & Generics

More from United Kingdom